التفاصيل البيبلوغرافية
العنوان:
SAFETY AND EFFICACY OF STATIN MANAGEMENT DURING GLECAPREVIR/PIBRENTASVIR TREATMENT FOR CHRONIC HEPATITIS C
المؤلفون:
Joseph Gathe , Peter Jones , Ariel Porcalla , Federico J. Mensa , Lisa Barcomb , Paul Kwo , Yao Yu , Peter Toth , Douglas E. Dylla
المصدر:
Journal of the American College of Cardiology . 71:A1763
بيانات النشر:
Elsevier BV, 2018.
سنة النشر:
2018
مصطلحات موضوعية:
0301 basic medicine , medicine.medical_specialty , Statin , business.industry , medicine.drug_class , 030106 microbiology , nutritional and metabolic diseases , Glecaprevir , Pibrentasvir , Virus , 03 medical and health sciences , 0302 clinical medicine , Chronic hepatitis , Concomitant , Internal medicine , Medicine , lipids (amino acids, peptides, and proteins) , 030211 gastroenterology & hepatology , Rosuvastatin , Cardiology and Cardiovascular Medicine , business , Pravastatin , medicine.drug
الوصف:
Some statins are not recommended for concomitant use with glecaprevir/pibrentasvir (G/P) treatment for chronic hepatitis C virus infection. We analyzed the impact of switching to rosuvastatin or pravastatin compared to maintaining or interrupting current statin use. Safety and efficacy data from
تدمد:
0735-1097
DOI:
10.1016/s0735-1097(18)32304-0
URL الوصول:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4571d300bf101189df8e4a049b314b7 https://doi.org/10.1016/s0735-1097 (18)32304-0
Rights:
CLOSED
رقم الانضمام:
edsair.doi...........e4571d300bf101189df8e4a049b314b7
قاعدة البيانات:
OpenAIRE